These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8193521)
101. An approach to the explanation of cell membrane alteration in primary hypertension. Postnov YV Hypertension; 1990 Mar; 15(3):332-7. PubMed ID: 1689273 [No Abstract] [Full Text] [Related]
102. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Dahlöf B; Lindholm LH; Hansson L; Scherstén B; Ekbom T; Wester PO Lancet; 1991 Nov; 338(8778):1281-5. PubMed ID: 1682683 [TBL] [Abstract][Full Text] [Related]
103. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ; 1992 Feb; 304(6824):405-12. PubMed ID: 1445513 [TBL] [Abstract][Full Text] [Related]
104. Hypertension and coronary heart disease risk factor management. Houston MC Clin Auton Res; 1993 Dec; 3(6):357-61. PubMed ID: 8193521 [TBL] [Abstract][Full Text] [Related]
105. New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension. Houston MC Am Heart J; 1989 Apr; 117(4):911-51. PubMed ID: 2648781 [TBL] [Abstract][Full Text] [Related]
106. The management of hypertension and associated risk factors for the prevention of long-term cardiac complications. Houston MC J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S2-13. PubMed ID: 7692147 [TBL] [Abstract][Full Text] [Related]
107. New insights and approaches to reduce end-organ damage in the treatment of hypertension: subsets of hypertension approach. Houston MC Am Heart J; 1992 May; 123(5):1337-67. PubMed ID: 1575152 [TBL] [Abstract][Full Text] [Related]
108. Hypertension strategies for therapeutic intervention and prevention of end-organ damage. Houston MC Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795 [TBL] [Abstract][Full Text] [Related]
109. The Role of Beta-Blockers in the Treatment of Hypertension. Cruickshank JM Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711 [TBL] [Abstract][Full Text] [Related]
110. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
114. [New therapeutic outlooks in the treatment of the hypertensive patient]. Ambrosioni E; Bacchelli S; Borghi C Ann Ital Med Int; 1995 Oct; 10 Suppl():78S-81S. PubMed ID: 8562273 [TBL] [Abstract][Full Text] [Related]
115. Antihypertensive therapy in diabetic patients. Weidmann P; Boehlen LM; de Courten M; Ferrari P J Hum Hypertens; 1992 Dec; 6 Suppl 2():S23-36. PubMed ID: 1289510 [TBL] [Abstract][Full Text] [Related]
116. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond. Kirchengast M J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195 [TBL] [Abstract][Full Text] [Related]